Dermatology Times

CONTINUE TO SITE >

OR WAIT 15 SECS

Acne Managing Papulopustular Rosacea Molecular Mechanisms of Wound Healing Psoriasis The Changing Treatment Landscape of Plaque Psoriasis

Acne Anti-Aging Atopic Dermatitis Hair & Scalp Psoriasis Rosacea Skin Cancer (Melanoma)Skin Cancer (Non-Melanoma)Women's Health

Device Technology Drug Watch Legal Lifestyle NP and PA Practice Management

Expert Interviews Medical World News Podcasts Viewpoints

Conference Coverage Conference Listing Maui Derm

Education Image IQ Interactive Tools Job Board Polls Sponsored Resources

eNewsletter Print Subscription

Advertise
Contact Us
Job Board
Do Not Sell My Information
Terms and Conditions
Privacy Policy

© 2021 MJH Life Sciences and Dermatology Times and Multimedia Medical, LLC. All rights reserved.

Spotlight

Acne
Managing Papulopustular Rosacea
Molecular Mechanisms of Wound Healing
Psoriasis
The Changing Treatment Landscape of Plaque Psoriasis

TopicsSee All >

Acne
Anti-Aging
Atopic Dermatitis
Hair & Scalp
Psoriasis
Rosacea
Skin Cancer (Melanoma)
Skin Cancer (Non-Melanoma)
Women's Health

Advertise
Contact Us
Job Board
Do Not Sell My Information
Terms and Conditions
Privacy Policy

© 2021 MJH Life Sciences^™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.

Rosacea Relief

February 1, 2003

Las Vegas - The FDA on Jan. 2 cleared Berlex Laboratories Inc. to market Finacea (azelaic acid 15 percent) gel for the treatment of rosacea.

Related Content: